Expression levels of circulating mirnas as biomarkers during multimodal treatment of rectal cancer – timisnar-mirna: a substudy of the timisnar trial (nct03962088)

HIGHLIGHTS

• who: Igor Monsellato from the Department of Surgery, Azienda Ospedaliera SSAntonio e Biagio e Cesare Arrigo, Via Venezia, Alessandria, Italy have published the paper: Expression levels of circulating miRNAs as biomarkers during multimodal treatment of rectal cancer - TiMiSNAR-mirna: a substudy of the TiMiSNAR Trial (NCT03962088), in the Journal: (JOURNAL) of 23/05/2019
• what: The aim of the study is to investigate the role of circulating miRNAs as biomarkers in those patients included in the TiMiSNAR Trial (NCT 03465982).
• how: The nCounter miRNA Expression Assay (NanoString Technologies Seattle WA USA) is designed . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.